p38 Mitogen activated protein kinase (MAPK): a new therapeutic target for reducing the risk of adverse pregnancy outcomes

Research output: Contribution to journalReview articlepeer-review

33 Scopus citations

Fingerprint

Dive into the research topics of 'p38 Mitogen activated protein kinase (MAPK): a new therapeutic target for reducing the risk of adverse pregnancy outcomes'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds